Authors: Hurwitz, SJ Ma, L Eleuteri, A Wright, J Moravek, J Schinazi, RF

Citation: Sj. Hurwitz et al., Cellular pharmacology of the D- and L-enantiomers of beta-5-o-carboranyl-2'-deoxyuridine, NUCLEOS NUC, 19(3), 2000, pp. 691-702

Authors: Schinazi, RF Hurwitz, SJ Liberman, I Juodawlkis, AS Tharnish, P Shi, JX Liotta, DC Coderre, JA Olson, J

Citation: Rf. Schinazi et al., Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2 '-deoxyuridine neutron capture therapy, CLIN CANC R, 6(2), 2000, pp. 725-730

Authors: Mourier, NS Eleuteri, A Hurwitz, SJ Tharnish, PM Schinazi, RF

Citation: Ns. Mourier et al., Enantioselective synthesis and biological evaluation of 5-o-carboranyl pyrimidine nucleosides, BIO MED CH, 7(12), 1999, pp. 2759-2766

Authors: Ma, L Hurwitz, SJ Shi, JX McAtee, JJ Liotta, DC McClure, HM Schinazi, RF

Citation: L. Ma et al., Pharmacokinetics of the antiviral agent beta-D-2 ',3 '-didehydro-2 ',3 '-dideoxy-5-fluorocytidine in rhesus monkeys, ANTIM AG CH, 43(2), 1999, pp. 381-384

Authors: Hurwitz, SJ Tennant, BC Korba, BE Gerin, JL Schinazi, RF

Citation: Sj. Hurwitz et al., Pharmacodynamics of (-)-beta-2 ',3 '-dideoxy-3 '-thiacytidine in chronically virus-infected woodchucks compared to its pharmacodynamics in humans (vol 42, pg 2804, 1998), ANTIM AG CH, 42(12), 1998, pp. 3337-3337